Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis

https://m2.mtmt.hu/ hun 2026-04-29 09:25 JournalArticle 36063902 APPROVED true 0 false 2026-03-05T14:53:46.604+0000 2025-03-28T14:09:55.129+0000 2025-03-28T14:07:17.764+0000 true 10094194 Kozma Bernadett /api/admin/10094194 Admin Kozma Bernadett (KK_AOK_Mellkassebeszet_Admin5_KB, admin) true 2025-03-28T14:07:37.681+0000 2025-03-28T14:07:37.681+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Ostoros, Gyula Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis true true /api/journal/10006979 REVIEWED EXPERT REVIEW OF ANTICANCER THERAPY 1473-7140 1744-8328 true false 10006979 false 10006979 true 1473-7140 1744-8328 Journal FOREIGN 23 12 1305 1313 1305 9 2023 true true 2025 true true true false false NONE 2026-03-05 false 3 1 3 3 0 3 3 3 2 3 3 3 3 3 0 0 3 3 3 3 0 0 0 Folyóiratcikk Journal Article 24 3 Könyvrészlet Chapter in Book 25 0 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2024 0 1 1 1 1 2025 0 2 2 2 2 Q2 false false false false 2025-06-26T13:07:37.482+0000 1 2 0 10 0 true Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 125774231 /api/authorship/125774231 Ostoros, Gyula [Ostoros, Gyula (Pulmonológia), szerző] 1 0.1 true false false Author 10029172 /api/author/10029172 Ostoros Gyula (Pulmonológia) Ostoros Gyula true 10029172 true Ostoros Gyula true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 125774232 /api/authorship/125774232 Hettle, Robert 2 0.1 false false false Hettle Robert true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 125774233 /api/authorship/125774233 Georgoulia, Nefeli 3 0.1 false false false Georgoulia Nefeli true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 125774234 /api/authorship/125774234 Berktas, Mehmet 4 0.1 false false false Berktas Mehmet true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 125774235 /api/authorship/125774235 Chander, Pratibha 5 0.1 false false false Chander Pratibha true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 125774236 /api/authorship/125774236 Diaz Perez, Ignacio 6 0.1 false false false Diaz Perez Ignacio true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 125774237 /api/authorship/125774237 Couto, Anne-Marie 7 0.1 false false false Couto Anne-Marie true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 125774238 /api/authorship/125774238 Eichinger, Christian 8 0.1 false false false Eichinger Christian true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 125774239 /api/authorship/125774239 Field, Polly 9 0.1 false false false Field Polly true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 125774240 /api/authorship/125774240 Morten, Peter 10 0.1 false true false Morten Peter true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 29171632 /api/publicationidentifier/29171632 DOI: 10.1080/14737140.2023.2272645 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true 10.1080/14737140.2023.2272645 https://doi.org/10.1080/14737140.2023.2272645 false true PublicationIdentifier 29171634 /api/publicationidentifier/29171634 WoS: 001090516600001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001090516600001 https://www.webofscience.com/wos/woscc/full-record/001090516600001 false true PublicationIdentifier 29171653 /api/publicationidentifier/29171653 Scopus: 85174829181 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true 85174829181 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85174829181 true true PublicationIdentifier 29171633 /api/publicationidentifier/29171633 Egyéb URL: https://www.tandfonline.com/doi/full/10.1080/14737140.2023.2272645 PlainSource 40 /api/publicationsource/40 Egyéb URL PublicationSourceType 10006 /api/publicationsourcetype/10006 Link true true true Egyéb URL Other URL @@@ true true 40 true https://www.tandfonline.com/doi/full/10.1080/14737140.2023.2272645 https://www.tandfonline.com/doi/full/10.1080/14737140.2023.2272645 false true SjrRating 11403721 /api/sjrrating/11403721 sjr:Q2 (2023) Scopus - Oncology EXPERT REVIEW OF ANTICANCER THERAPY 1473-7140 1744-8328 158 0.49 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 2730 /api/classificationexternal/2730 Scopus - Oncology true 2730 true Q2 DIRECT true true Reference 65104684 /api/reference/65104684 1. DOI: 10.3322/caac.21660 1 10.3322/caac.21660 false true Reference 65104685 /api/reference/65104685 2. Cancer.Net. Lung cancer - non-small cell: statistics. 2022 [Accessed 2023 Nov 16]. Available at: https://www.cancer.net/cancer-types/lung-cancer-non-small-cell/statistics. 2 false true Reference 65104686 /api/reference/65104686 3. DOI: 10.1200/JCO.21.02528 3 10.1200/JCO.21.02528 false true Reference 65104687 /api/reference/65104687 4. DOI: 10.1093/annonc/mdx222 4 10.1093/annonc/mdx222 false true Reference 65104688 /api/reference/65104688 5. National Comprehensive Cancer Network. NCCN guidelines version 5.2022. Non-small cell lung cancer. [Accessed 2022 Nov 16]. Available at: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf. 5 false true Reference 65104689 /api/reference/65104689 6. Clinicaltrials.gov. A study of neoadjuvant/adjuvant durvalumab for the treatment of patients with resectable non-small cell lung cancer (AEGEAN). [Accessed 2022 Jul 5]. Available at: https://www.clinicaltrials.gov/ct2/show/NCT03800134. 6 false true Reference 65104690 /api/reference/65104690 7. Clinicaltrials.gov. A neoadjuvant study of nivolumab plus ipilimumab or nivolumab plus chemotherapy versus chemotherapy alone in early stage non-small cell lung cancer (NSCLC) (CheckMate 816). [Accessed 2022 Jul 5]. Available at: https://clinicaltrials.gov/ct2/show/NCT02998528. 7 false true Reference 65104691 /api/reference/65104691 8. Clinicaltrials.gov. A study of neoadjuvant chemotherapy plus nivolumab versus neoadjuvant chemotherapy plus placebo followed by surgical removal and adjuvant treatment with nivolumab or placebo for participants with surgically removable early stage non-small cell lung cancer. [Accessed 2022 Jul 7]. Available at: https://www.clinicaltrials.gov/ct2/show/NCT04025879. 8 false true Reference 65104692 /api/reference/65104692 9. Clinicaltrials.gov. A study of neoadjuvant atezolizumab plus chemotherapy versus placebo plus chemotherapy in patients with resectable stage II IIIA or select IIIB non-small cell lung cancer (IMpower030). [Accessed 2022 Jul 7]. Available at: https://www.clinicaltrials.gov/ct2/show/NCT03456063. 9 false true Reference 65104693 /api/reference/65104693 10. Clinicaltrials.gov. Efficacy and safety of pembrolizumab (MK-3475) with platinum doublet chemotherapy as neoadjuvant/adjuvant therapy for participants with resectable stage II IIIA and resectable IIIB (T3-4N2) non-small cell lung cancer (MK-3475-671/KEYNOTE-671). [Accessed 2022 Jul 7]. Available at: https://www.clinicaltrials.gov/ct2/show/NCT03425643. 10 false true Reference 65104694 /api/reference/65104694 11. FDA. FDA approves neoadjuvant nivolumab and platinum-doublet chemotherapy for early-stage non-small cell lung cancer. [Accessed 2022 Aug 23]. Available at: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-neoadjuvant-nivolumab-and-platinum-doublet-chemotherapy-early-stage-non-small-cell-lung. 11 false true Reference 65104695 /api/reference/65104695 12. DOI: 10.2147/CMAR.S328058 12 10.2147/CMAR.S328058 false true Reference 65104696 /api/reference/65104696 13. FDA. Clinical trial endpoints for the approval of cancer drugs and biologics. Guidance For Industry. 2018 [Accessed 2022 Jul 26]. Available at: https://www.fda.gov/media/71195/download. 13 false true Reference 65104697 /api/reference/65104697 14. National Institute for Health and Care Excellence. Osimertinib for adjuvant treatment of EGFR mutation-positive non-small-cell lung cancer after complete tumour resection. [Accessed 2022 Aug 23]. Available at: https://www.nice.org.uk/guidance/ta761/resources/osimertinib-for-adjuvant-treatment-of-egfr-mutationpositive-nonsmallcell-lung-cancer-after-complete-tumour-resection-pdf-82611430864837. 14 false true Reference 65104698 /api/reference/65104698 15. National Institute for Health and Care Excellence. Atezolizumab for adjuvant treatment of resected non-small-cell lung cancer. [Accessed 2022 Sep 29]. Available at: https://www.nice.org.uk/guidance/ta823. 15 false true Reference 65104699 /api/reference/65104699 16. Risk of bias info. [Accessed 2022 Nov 28]. Available at: https://www.riskofbias.info/welcome. 16 false true Reference 65104700 /api/reference/65104700 17. Cochrane Methods. Risk of bias in non-randomized studies - of interventions (ROBINS-I). [Accessed 2022 Nov 28]. Available at: https://methods.cochrane.org/bias/risk-bias-non-randomized-studies-interventions. 17 false true Reference 65104701 /api/reference/65104701 18. DOI: 10.3389/fonc.2021.672916 18 10.3389/fonc.2021.672916 false true Reference 65104702 /api/reference/65104702 19. DOI: 10.1016/j.jval.2016.10.011 19 10.1016/j.jval.2016.10.011 false true Reference 65104703 /api/reference/65104703 20. DOI: 10.3310/hta13080 20 10.3310/hta13080 false true Reference 65104704 /api/reference/65104704 21. DOI: 10.1002/sim.6778 21 10.1002/sim.6778 false true Reference 65104705 /api/reference/65104705 22. DOI: 10.1093/jncics/pkz002 22 10.1093/jncics/pkz002 false true Reference 65104706 /api/reference/65104706 23. DOI: 10.1136/bmj-2021-066381 23 10.1136/bmj-2021-066381 false true Reference 65104707 /api/reference/65104707 24. DOI: 10.1016/S0140-6736(09)60737-6 24 10.1016/S0140-6736(09)60737-6 false true Reference 65104708 /api/reference/65104708 25. DOI: 10.2147/OTT.S44503 25 10.2147/OTT.S44503 false true Reference 65104709 /api/reference/65104709 26. DOI: 10.1002/cncr.26689 26 10.1002/cncr.26689 false true Reference 65104710 /api/reference/65104710 27. DOI: 10.1016/S1470-2045(08)70156-6 27 10.1016/S1470-2045(08)70156-6 false true Reference 65104711 /api/reference/65104711 28. DOI: 10.1093/jnci/djk093 28 10.1093/jnci/djk093 false true Reference 65104712 /api/reference/65104712 29. DOI: 10.1200/JCO.2009.27.6204 29 10.1200/JCO.2009.27.6204 false true Reference 65104713 /api/reference/65104713 30. DOI: 10.1200/JCO.2009.26.1685 30 10.1200/JCO.2009.26.1685 false true Reference 65104714 /api/reference/65104714 31. DOI: 10.1016/S0140-6736(07)60714-4 31 10.1016/S0140-6736(07)60714-4 false true Reference 65104715 /api/reference/65104715 32. DOI: 10.1016/j.jtcvs.2018.09.098 32 10.1016/j.jtcvs.2018.09.098 false true Reference 65104716 /api/reference/65104716 33. DOI: 10.1016/j.lungcan.2018.02.008 33 10.1016/j.lungcan.2018.02.008 false true Reference 65104717 /api/reference/65104717 34. DOI: 10.1016/j.ijrobp.2018.02.003 34 10.1016/j.ijrobp.2018.02.003 false true Reference 65104718 /api/reference/65104718 35. DOI: 10.1200/EDBK_321483 35 10.1200/EDBK_321483 false true Reference 65104719 /api/reference/65104719 36. DOI: 10.1056/NEJMoa2202170 36 10.1056/NEJMoa2202170 false true Reference 65104720 /api/reference/65104720 37. Provencio M, Serna R, Nadal E, et al. Nivolumab + chemotherapy vs chemotherapy as neoadjuvant treatment for resectable IIIA-B NSCLC. Progression-free survival and overall survival results from the phase 2 NADIM II trial [oral presentation]. Presented at the World Conference on Lung Cancer; 2022 Aug 6–9; Vienna, Austria. 37 false true Reference 65104721 /api/reference/65104721 38. DOI: 10.1016/j.annonc.2020.08.116 38 10.1016/j.annonc.2020.08.116 false true Reference 65104722 /api/reference/65104722 39. DOI: 10.1016/j.ajodo.2019.12.011 39 10.1016/j.ajodo.2019.12.011 false true /api/publication/36063902 Ostoros Gyula et al. Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis. (2023) EXPERT REVIEW OF ANTICANCER THERAPY 1473-7140 1744-8328 23 12 1305-1313<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10029172"><a href="/gui2/?type=authors&mode=browse&sel=10029172" target="_blank">Ostoros Gyula (<span class="authorship-author-name">Ostoros Gyula</span> <span class="authorAux-mtmt"> Pulmonológia</span>) </a> </span> ;    <span class="author-name" >Hettle Robert </span> ;    <span class="author-name" >Georgoulia Nefeli </span> ;    <span class="author-name" >Berktas Mehmet </span> ;    <span class="author-name" >Chander Pratibha </span> ;    <span class="author-name" >Diaz Perez Ignacio </span> ;    <span class="author-name" >Couto Anne-Marie </span> ;    <span class="author-name" >Eichinger Christian </span> ;    <span class="author-name" >Field Polly </span> ;    <span class="author-name" >Morten Peter </span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;36063902" target="_blank">Association between event-free survival and overall survival after neoadjuvant treatment for non-small cell lung cancer: a systematic review and meta-analysis</a></div> <div> <span class="journal-title">EXPERT REVIEW OF ANTICANCER THERAPY</span> <span class="journal-issn">(<a target="_blank" href="https://portal.issn.org/resource/ISSN/1473-7140">1473-7140</a> <a target="_blank" href="https://portal.issn.org/resource/ISSN/1744-8328">1744-8328</a>)</span>: <span class="journal-volume">23</span> <span class="journal-issue">12</span> <span class="page"> pp 1305-1313 </span> <span class="year">(2023)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_none" title="none"> <a style="color:black" title="10.1080/14737140.2023.2272645" target="_blank" href="https://doi.org/10.1080/14737140.2023.2272645"> DOI </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001090516600001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001090516600001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:black" title="85174829181" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85174829181"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:black" title="https://www.tandfonline.com/doi/full/10.1080/14737140.2023.2272645" target="_blank" href="https://www.tandfonline.com/doi/full/10.1080/14737140.2023.2272645"> Egyéb URL </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Oncology   SJR indikátor: Q2</div> <div class="journal-subject">Folyóirat szakterülete: Scopus - Pharmacology (medical)   SJR indikátor: Q2</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 3</span> | Független: 3 | Függő: 0 | Nem jelölt: 0 | WoS jelölt: 3 | Scopus jelölt: 2 | WoS/Scopus jelölt: 3 | DOI jelölt: 3 (Nem nyilvános: 1) </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 36063902</span> | <span class="status-data status-APPROVED"> Nyilvános </span> Forrás | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="lastModified">Utolsó módosítás: 2025.03.28. 15:09 Kozma Bernadett (KK_AOK_Mellkassebeszet_Admin5_KB, admin) </div> </div></div>